Trial Profile
A retrospective,observational study to evaluate genotypic information of Rilpivirine in treatment naive HIV-1 infected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2017
Price :
$35
*
At a glance
- Drugs Rilpivirine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 03 Mar 2017 New trial record